Stay updated on EYP-1901 in NPDR Clinical Trial
Sign up to get notified when there's something new on the EYP-1901 in NPDR Clinical Trial page.

Latest updates to the EYP-1901 in NPDR Clinical Trial page
- Check2 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while also removing extensive content related to various medical topics and a previous version revision.SummaryDifference2%
- Check9 days agoChange DetectedThe page has removed the phrase 'Last Update Posted (Estimated)' and replaced it with 'Last Update Posted'.SummaryDifference0.0%
- Check16 days agoChange DetectedThe page has been updated to reflect a new version (v2.16.12) and includes new dates for updates, replacing the previous version (v2.16.11) and older dates.SummaryDifference0.5%
- Check23 days agoChange DetectedThe page has updated the description of the Diabetic Retinopathy Severity Scale (DRSS) by changing the time points for severity assessment from Week 36 to Weeks 24 and 48, and it has also updated the revision number from v2.16.10 to v2.16.11.SummaryDifference0.8%
- Check30 days agoChange DetectedThe webpage has been updated to reflect the results of a recent study on the EYP-1901 intravitreal insert, including new locations for the study and changes in participant criteria. Additionally, the results reporting dates have been updated.SummaryDifference80%
- Check37 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.3%
Stay in the know with updates to EYP-1901 in NPDR Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EYP-1901 in NPDR Clinical Trial page.